A Follow-up Study on Safety and Tolerability and Pharmacodynamic Effect, of Patients With Idiopathic Parkinson's Disease (PD) of Moderate Severity, Who Have Previously Been Treated With sNN0031, Using an Implanted Catheter and a SynchroMed II Pump [FOLLOW-UP TO 700030728]
Phase of Trial: Phase I/II
Latest Information Update: 19 Nov 2014
At a glance
- Drugs SNN 0031 (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- Sponsors Medtronic
- 08 Oct 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov .
- 01 Jul 2014 Planned End Date changed from 1 Aug 2013 to 1 Aug 2014 according to ClinicalTrials.gov record.
- 01 Jul 2014 Planned primary completion date changed from 1 Aug 2013 to 1 Nov 2013 according to ClinicalTrials.gov record.